跳至主要内容
临床试验/EUCTR2009-014050-15-BE
EUCTR2009-014050-15-BE进行中(未招募)不适用

Conversion from a twice-daily tacrolimus (tac) regimen to a once-daily tacorlimus exended-release formulation (TacXL) regimen : Pharamcokinetic studies in stable cystic fibrosis (CF) and non-CF patients having received a pulmonary transplant - Tac-X

Hopital Erasme - Chest service0 个研究点开始时间: 2009年9月14日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - stable CF and non-CF patients having received a pulmonary transplant who did not represent an acute rejection during the 12 months before study entry
  • -patients who present with a normal or only moderate altered renal function (creatinine clearance > 50ml/dl)
  • - written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - patients on medications known to interfere with Tac metabolism (ie. isoniazide, rifampicin, aticonvulsivants, azole anti-fungal agents).

研究者

发起方
Hopital Erasme - Chest service

相似试验